HOME 201920182017 TOTAAL AML CLINICAL TRIALS GENETICA HEMATOPOIESE IMMUNOLOGIEINNOVATIE LEUKEMIE LYMFOMEN MYELOOM OPINIE ASH TOPPUBLICATIES Dr. M. Brink When performance of cytogenetics matters: a population-based study in The Netherlands on newly diagnosed multiple myeloma patients naar Totaal Terug